Teva to Present at the UBS Global Life Sciences Conference
September 23, 2008
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the UBS Global Life Sciences Conference in New York.
Eyal Desheh, Chief Financial Officer, will present on September 24, 2008.
What: Teva Presentation at the UBS Global Life Sciences Conference in New York Who: Eyal Desheh, Chief Financial Officer When: Wednesday, September 24, 2008 at 3:00 p.m. ET Where: www.tevapharm.com or http://events.streamx.us/US/event/eventdetails.aspx?id=ubs20080922 How: Live over the Internet — log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva’s website.
About Teva
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world’s leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva’s sales are in North America and Europe.